232 related articles for article (PubMed ID: 10635617)
1. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris.
Hertl M; Riechers R
J Dermatol; 1999 Nov; 26(11):748-52. PubMed ID: 10635617
[TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular autoimmunity in autoimmune bullous skin disorders.
Hertl M
Int Arch Allergy Immunol; 2000 Jun; 122(2):91-100. PubMed ID: 10878487
[TBL] [Abstract][Full Text] [Related]
3. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
[TBL] [Abstract][Full Text] [Related]
5. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.
Hertl M; Amagai M; Sundaram H; Stanley J; Ishii K; Katz SI
J Invest Dermatol; 1998 Jan; 110(1):62-6. PubMed ID: 9424089
[TBL] [Abstract][Full Text] [Related]
6. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals.
Hertl M; Karr RW; Amagai M; Katz SI
J Invest Dermatol; 1998 Apr; 110(4):388-92. PubMed ID: 9540980
[TBL] [Abstract][Full Text] [Related]
8. T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin.
Hertl M; Veldman C
Autoimmun Rev; 2003 Sep; 2(5):278-83. PubMed ID: 12965179
[TBL] [Abstract][Full Text] [Related]
9. Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris.
Didona D; Scarsella L; Hudemann C; Volkmann K; Zimmer CL; Beckert B; Tikkanen R; Korff V; Kühn K; Wienzek-Lischka S; Bein G; Di Zenzo G; Böhme J; Cunha T; Solimani F; Pieper J; Juratli HA; Göbel M; Schmidt T; Borradori L; Yazdi AS; Sitaru C; Garn H; Eming R; Fleischer S; Hertl M
J Invest Dermatol; 2024 Feb; 144(2):263-272.e8. PubMed ID: 37717934
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.
Lin MS; Swartz SJ; Lopez A; Ding X; Fernandez-Vina MA; Stastny P; Fairley JA; Diaz LA
J Clin Invest; 1997 Jan; 99(1):31-40. PubMed ID: 9011573
[TBL] [Abstract][Full Text] [Related]
11. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.
Veldman C; Höhne A; Dieckmann D; Schuler G; Hertl M
J Immunol; 2004 May; 172(10):6468-75. PubMed ID: 15128839
[TBL] [Abstract][Full Text] [Related]
12. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
[TBL] [Abstract][Full Text] [Related]
13. HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy.
Riechers R; Grötzinger J; Hertl M
Autoimmunity; 1999; 30(3):183-96. PubMed ID: 10520901
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
[TBL] [Abstract][Full Text] [Related]
15. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
Aoyama Y; Owada MK; Kitajima Y
Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
[TBL] [Abstract][Full Text] [Related]
16. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris.
Takahashi H; Amagai M; Nishikawa T; Fujii Y; Kawakami Y; Kuwana M
J Immunol; 2008 Jul; 181(2):1526-35. PubMed ID: 18606708
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
[TBL] [Abstract][Full Text] [Related]
18. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.
Pollmann R; Schmidt T; Eming R; Hertl M
Clin Rev Allergy Immunol; 2018 Feb; 54(1):1-25. PubMed ID: 29313220
[TBL] [Abstract][Full Text] [Related]
20. Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus.
Futei Y; Amagai M; Hashimoto T; Nishikawa T
J Am Acad Dermatol; 2003 Dec; 49(6):1023-8. PubMed ID: 14639380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]